, Volume 14, Issue 6, pp 413–417 | Cite as

Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas

  • T. E. Adrian
  • S. R. Bloom
  • K. Hermansen
  • J. Iversen


The release of pancreatic polypeptide (PP) by gut hormones, acetyl choline and adrenaline was investigated in an isolated perfused pancreas preparation. PP was potently released by 1 nmol/l caerulein (186±12%, p<0.001) and gastric inhibitory peptide (GIP) (211±31%, p<0.005) as well as by 1 [νmol/l acetyl choline (1097±59%, p<0.001). A significant two-fold release of PP was also evoked by 1 nmol/l vasoactive intestinal peptide (VIP) (129±38%, p<0.02 and gastrin (108±25% p<0.01). Insulin release, induced by high glucose concentration was enhanced by both GIP (210 ±38%, p<(0.01) and VIP (48±5%, p<0.001). In addition GIP enhanced the release of glucagon by 179±18% (p<0.001) at 1.4 mmol/l glucose and by 127±24% (p<0.005) at 8.3 mmol/l glucose. Thus no simple inter-relationship appears to exist between the control of the three circulating islet hormones.

Key words

Isolated perfused canine pancreas VIP GIP caerulein gastrin secretin glucagon bombesin acetyl choline adrenaline release of insulin release of glucagon release of PP 


  1. 1.
    Adrian, T. E., Bloom, S. R., Besterman, H. S., Barnes, A. J., Cooke, T. J. C., Russell, R. C. G., Faber, R. C.: Mechanism of pancreatic polypeptide release in man. Lancet1977 I, 161–163Google Scholar
  2. 2.
    Floyd, J. C., Fajans, S. S., Pek, S.: Regulation in healthy subjects of the secretion of human pancreatic polypeptide, a newly recognised pancreatic islet polypeptide. Recent Prog. Horm. Res.33, 519–570 (1977)Google Scholar
  3. 3.
    Iversen, J.: Secretion of glucagon from the isolated perfused canine pancreas. J. Clin. Invest.50, 2123–2136 (1971)PubMedGoogle Scholar
  4. 4.
    Iversen, J.: Adrenergic receptors and the secretion of glucagon and insulin from the isolated perfused canine pancreas. J. Clin. Invest.52, 2102–2116 (1973)PubMedGoogle Scholar
  5. 5.
    Iversen, J.: Inhibition of pancreatic glucagon release by somatostatin: in vitro. Scand. J. Clin. Invest.33, 125–129 (1974)PubMedGoogle Scholar
  6. 6.
    Iversen, J., Miles, D. W.: Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas. Diabetes20, 1–9 (1971)PubMedGoogle Scholar
  7. 7.
    Ørskov, H.: Wick chromatography for the immunoassay of insulin. Scand. J. Clin. Lab. Invest.20, 297–304 (1967)Google Scholar
  8. 8.
    Ørskov, H., Thomsen, H. G., Yde, H.: Wick chromatography for the rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature219, 193–195 (1968)Google Scholar
  9. 9.
    Adrian, T. E., Bloom, S. R., Bryant, M. G., Polak, J. M., Heitz, Ph., Barnes, A. J.: Distribution and release of human pancreatic polypeptide. Gut17, 940–944 (1976)PubMedGoogle Scholar
  10. 10.
    Iversen, J.: Effect of acetyl choline on the secretion of glucagon and insulin from the isolated perfused canine pancreas. Diabetes22, 381–387 (1973)PubMedGoogle Scholar
  11. 11.
    Schwartz, T. W., Stadil, F., Chance, R. E., Rehfeld, J. E., Larsson, L. I., Moon, N.: Pancreatic polypeptide response to food in duodenal ulcer patients before and after vagotomy. Lancet1976 I, 1102–1105Google Scholar
  12. 12.
    Schwartz, T. W., Rehfeld, J. J.: Mechanism of pancreatic-polypeptide release. Lancet1977 I, 697–698Google Scholar
  13. 13.
    Samols, E., Weir, G. C., Patel, Y. C., Loo, S. W., Gabbay, K. H.: Autonomic control of somatostatin and pancreatic peptide secretion by the isolated perfused canine pancreas. Clin. Res.25, 499A (1977)Google Scholar
  14. 14.
    Adrian, T. E., Besterman, H. S., Mallinson, C. N., Czaykowska, W. M., Bloom, S. R.: Studies on the release of pan-creatic polypeptide and its relationship to pancreatic exocrine function. J. Endocrinol.75, 35 P (1977)Google Scholar
  15. 15.
    Larson, L. I., Sundler, F., Hakanson, R.: Pancreatic polypeptide — a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia12, 211–226 (1976)PubMedGoogle Scholar
  16. 16.
    Bloom, S. R., Polak, J. M.: Peptidergic versus purinergic. Lancet1978 I, 93Google Scholar
  17. 17.
    Bryant, M. G., Bloom, S. R., Polak, J. M., Albuquerque, R. H., Modlin, I., Pearse, A. G.E.: Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet1976 I, 991–993Google Scholar
  18. 18.
    Sundler, F., Alumets, J., Hakanson, R.: Peptides in the gut with a dual distribution in nerves and endocrine cells. In: S. R. Bloom (Ed): Gut Hormones, pp. 406–413. Edinburgh: Churchill Livingstone 1978Google Scholar

Copyright information

© Springer-Verlag 1978

Authors and Affiliations

  • T. E. Adrian
    • 1
  • S. R. Bloom
    • 1
  • K. Hermansen
    • 1
    • 2
  • J. Iversen
    • 1
    • 2
  1. 1.Department of MedicineRoyal Postgraduate Medical SchoolLondonEngland
  2. 2.Second University Clinic of Internal MedicineKommunehospitalet, AarhusDenmark

Personalised recommendations